G Schmutz

535 total citations
9 papers, 329 citations indexed

About

G Schmutz is a scholar working on Hepatology, Infectious Diseases and Virology. According to data from OpenAlex, G Schmutz has authored 9 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hepatology, 4 papers in Infectious Diseases and 4 papers in Virology. Recurrent topics in G Schmutz's work include Hepatitis C virus research (5 papers), HIV Research and Treatment (4 papers) and HIV/AIDS drug development and treatment (4 papers). G Schmutz is often cited by papers focused on Hepatitis C virus research (5 papers), HIV Research and Treatment (4 papers) and HIV/AIDS drug development and treatment (4 papers). G Schmutz collaborates with scholars based in Germany, Estonia and United Kingdom. G Schmutz's co-authors include Stefan Mauss, F. Berger, Javier Murillas, Jochen Bäuerle, Ulrich A. Walker, Josep Mallolas, Rosa Miquel, Bernhard Setzer, Montse Laguno and José M. Gatell and has published in prestigious journals such as Hepatology, Clinical Infectious Diseases and Journal of Hepatology.

In The Last Decade

G Schmutz

9 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G Schmutz Germany	5	227	216	111	66	50	9	329
Giuseppe Barbaro Italy	8	261 1.1×	245 1.1×	62 0.6×	54 0.8×	31 0.6×	9	356
D. Nolan Australia	6	172 0.8×	129 0.6×	236 2.1×	171 2.6×	90 1.8×	11	370
Montse Laguno Spain	4	83 0.4×	79 0.4×	96 0.9×	67 1.0×	43 0.9×	4	181
Yann Quertainmont France	7	114 0.5×	64 0.3×	85 0.8×	37 0.6×	35 0.7×	14	200
Rama Kapoor United States	6	223 1.0×	167 0.8×	83 0.7×	16 0.2×	9 0.2×	8	270
Ilaria Caramma Italy	10	129 0.6×	87 0.4×	107 1.0×	17 0.3×	92 1.8×	14	245
María Jesús Jiménez‐Expósito United States	8	162 0.7×	163 0.8×	67 0.6×	46 0.7×	34 0.7×	12	266
Sheila Tumilty United States	7	355 1.6×	373 1.7×	94 0.8×	42 0.6×	12 0.2×	10	416
Elgin Green United States	6	74 0.3×	31 0.1×	224 2.0×	127 1.9×	111 2.2×	9	378
Guenther Schmutz Germany	10	233 1.0×	202 0.9×	244 2.2×	116 1.8×	107 2.1×	19	444

Countries citing papers authored by G Schmutz

Since Specialization

Citations

This map shows the geographic impact of G Schmutz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Schmutz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Schmutz more than expected).

Fields of papers citing papers by G Schmutz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Schmutz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Schmutz. The network helps show where G Schmutz may publish in the future.

Co-authorship network of co-authors of G Schmutz

This figure shows the co-authorship network connecting the top 25 collaborators of G Schmutz. A scholar is included among the top collaborators of G Schmutz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Schmutz. G Schmutz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Ingiliz, Patrick, Stefan Christensen, Torben Kimhofer, et al.. (2016). Sofosbuvir and Ledipasvir for 8 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in HCV-Monoinfected and HIV-HCV–Coinfected Individuals: Results From the German Hepatitis C Cohort (GECCO-01). Clinical Infectious Diseases. 63(10). 1320–1324. 44 indexed citations

Cornberg, Markus, Peter Buggisch, G Schmutz, et al.. (2016). Treatment of Patients with Hepatitis C Virus (HCV) Genotype 3 Infection in the Era of Direct Acting Antivirals (DAA): Data from the German Hepatitis C-Registry (DHC-R). Journal of Hepatology. 64(2). S794–S794. 1 indexed citations

Christensen, Stefan, Patrick Ingiliz, Knud Schewe, et al.. (2016). Relapse and Treatment-Emergent RAVS with DAA-Based Regimens in Hepatitis C Virus (HCV) Mono- or Human Immunodeficiency Virus (HIV)-HCV Co-Infected Patients – a Real Concern in Clinical Practice? Results from the German Hepatitis C Cohort (GECCO). Journal of Hepatology. 64(2). S821–S821. 3 indexed citations

Ingiliz, Patrick, Stefan Christensen, D. Hueppe, et al.. (2015). P0835 : German multicenter cohort on sofosbuvir-based treatments in HCV mono- and HIV/HCV co-infected patients (GECOSO). Journal of Hepatology. 62. S650–S650. 4 indexed citations

Walker, Ulrich A., Jochen Bäuerle, Montse Laguno, et al.. (2004). Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine. Hepatology. 39(2). 311–317. 123 indexed citations

Mauss, S, Stefan Scholten, Eva Wolf, et al.. (2004). A prospective, controlled study assessing the effect of lopinavir on amprenavir concentrations boosted by ritonavir. HIV Medicine. 5(1). 15–17. 8 indexed citations

Mauss, Stefan, et al.. (2004). A prospective controlled study of interferon-based therapy of chronic hepatitis C in patients on methadone maintenance. Hepatology. 40(1). 120–124. 128 indexed citations

Voigt, Esther, JC Wasmuth, M. Vogel, et al.. (2004). Safety, Efficacy and Development of Resistance under the New Protease Inhibitor Lopinavir/Ritonavir: 48-Week Results. Infection. 32(2). 82–88. 16 indexed citations

Mauss, Stefan & G Schmutz. (2001). Das HIV-assoziierte Lipodystrophiesyndrom. Medizinische Klinik. 96(7). 391–401. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact